Geneva, May 4 -- International Clinical Trials Registry received information related to the study (CTRI/2026/04/108888) titled 'Safety and Efficacy of the Puresta Sunscreen for Tan Reduction' on April 21.
Study Type: PMS
Study Design:
Single Arm Study Method of generating randomization sequence:Not Applicable Method of allocation concealment:Not Applicable Blinding and masking:Open Label
Primary Sponsor: Puresta Lifestyle Private Limited
Intervention:
Intervention1: Test Product: Sunscreen: Test Product: Sunscreen
Dose: 1-1.5 gm face & neck area thrice a day (Consider approx application of 2mg/cm2 or two finger rule could be used)
Route of Administration: Topical
Control Intervention1: Not Applicable: Not Applicable
Recruitme...